Capital Building in Washington DC

Advocacy & Policy

To improve patient care, ASCO advocates for increased federal funding for research, greater health care access, value in cancer care, and payment reform.

  • Exclusive Interview: NCI Director Ned Sharpless Talks Clinical Trials, Big Data

    In the latest ASCO in Action Podcast, ASCO CEO Dr. Clifford A. Hudis talks to NCI director Dr. Ned Sharpless about modernizing clinical trials, maximizing big data, and NCI's central role in leading cancer research.

    Listen Now
  • ASCO Urges Congress to Reject Proposed Changes to Medicare Part D

    ASCO recently urged CMS to protect patient access to necessary cancer care under Medicare Advantage (MA) and Medicare Part D, the proposed changes to which are aimed at lowering drug prices.

    Read More
  • New AMA RUC Survey on Physician Office Visits and Prolonged Services

    This important survey will help ASCO, in concert with the AMA's RUC, recommend accurate relative values for physician work and direct practice expenses to CMMS. ASCO members are encouraged to participate if they are invited to take the survey.

    Learn More

Random Quote

"ASCO is the world’s largest and arguably most influential oncology organization… a dynamic organization that not only is advancing the frontiers of research, providing outstanding educational opportunities, and defining standards of practice for clinical care, but also influencing public policy."
Anees Chagpar, MD
ASCO Member since 2003